Having trouble viewing this email? View in your browser.
ESCMID Logo

22 November 2016
WEEKLY NEWS

Dear colleagues,

Have a look at ESCMID’s press release or an article on its activities on the European Antibiotic Awareness Day. A summary of the AMR conference jointly organized by ESCMID and ASM was published in European Healthcare.

Best regards, your ESCMID communications editors

 

Parity Commission seeks new member from 2017

The ESCMID Parity Commission (EPC) was founded to review and improve the representation of minorities and gender as well as geographic balance in clinical microbiology and infectious diseases. It is seeking a new member for three years starting 2017 with the possibility of extension by two years. The aims and activities of the ESCMID Parity Commission may be viewed here.

› Read more
 

CMI highlight: Low response to pentavalent childhood vaccine in Laos

Researchers investigated the response to a pentavalent childhood vaccine (diphtheria, tetanus, whole cell pertussis, hepatitis B, Haemophilus influenzae type b) in Laos, a country where the high burden of vaccine-preventable diseases was thought to be due to low vaccine coverage. After a full documented course of vaccination, seroprotective rates were unusually low and disparate against components of the vaccine: only 38% of children were protected against hepatitis B, 56% against diphtheria and 85% against tetanus. Time since vaccination, age, home-birth and malnutrition only partially explained the poor vaccine responses. The study demonstrates an urgent need to monitor the serological response to vaccination, in particular in resource-poor countries, the researchers concluded.

› Read more
 

Post-doc opening in molecular and cellular microbiology in Brussels

The Cellular and Molecular Pharmacology department at the Louvain Drug Research Institute of the Université catholique de Louvain has a Post-doc opening (minimum two years) to study the biology of intracellular infection by Pseudomonas aeruginosa and to evaluate innovative therapeutic approaches. The project aims to characterize the interaction between eukaryotic cells and human pathogenic bacteria in the context of intracellular infection to better understand the cell response to infection and the reasons for poor response to antibiotic treatments. The work will consist of following the intracellular fate of bacteria and examining changes in bacterial gene expression during the infection process. The goal is to propose rational bases for innovative therapeutic strategies to be combined with antibiotics.

› Read more
 

ESCMID has a new ECC: a fungal research centre in Sari, Iran

The Medical Mycology/ Invasive Fungi Research Center at the School of Medicine, Mazandaran University of Medical Sciences, in Sari, Iran is the one of the country’s largest teaching and training departments specialized on MSc and PhD in fungal infections. The department is fully equipped to undertake molecular identification, antifungal drug resistance and epidemiologic studies of invasive fungal infections. In addition, it runs a specialized clinic for the diagnosis of fungal infections and has a very active research team focusing on the epidemiology of azole-resistant Aspergillus and Candida species.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.